Skip to Content

      Resources

      Sanofi Mini-Site

      Sanofi is proud to be an Executive Sponsor of the AMGA’s Rise to Immunize® campaign and to work together to improve rates of routine adult immunizations in the United States and reduce vaccine-preventable diseases. Sanofi is pleased to share unbranded resources for supporting influenza vaccinations.

      Provider Resources

      Flu Shot Importance Flashcard MAT-US-2505549-v1.0-06/2025

      This flashcard is a tool for Healthcare Providers to share the importance of flu vaccinations with patients and parents in the office setting.
      View Resource

      "Scaling Communication and Technology Enhancements to Drive Influenza Immunizations"

      This summary of the June 2025 RIZE webinar details how Henry Ford Medical Group has scaled communication and technology enhancements to drive influenza immunizations.
      View Resource

      Vaccine Hesitancy Toolkit MAT-US-2509318-v1.0-08/2025

      The Vaccine Hesitancy Toolkit provides Healthcare Providers and care teams with information and tools to tackle the topic of vaccine hesitancy with patients and/or parents to increase Vaccine Coverage Rates (VCR).
      View Resource

      “Implementing Population Health Immunization Strategies” Webinar

      This webinar details how improving immunization rates is a critical aspect of public health and preventative care, as well as how University of Washington has taken a team-based approach to overcome obstacles.
      View Resource

      Consumer/Patient Resources

      Vaccine Hesitancy Myth vs. Fact Brochure MAT-US-2509731-v1.0-08/2025

      This brochure is a patient-facing resource that debunks common vaccine myths so patients feel comfortable accepting their physician's recommendation for their immunizations.
      View Resource

      Flu Myth Busters Flashcard

      This flashcard dispels common myths and misconceptions surrounding the flu vaccine for adult patients.
      View Resource

      Flu Technology Flashcard

      Visual to differentiate egg/cell-based technology from recombinant technology.
      View Resource